The impact of discovering mutations of APP, PS1, and PS2 genes was profound, but the relevance of data from the observational and therapeutic studies with autosomal dominant mutation carriers to sporadic Alzheimer’s disease has gradually become less tenable (Morris et al., 2018). Here, APP is linked to Alzheimer disease.